Deep Track Capital, LP
Top Portfolio Positions
62 positions ·
$4,902,963,139 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
3,338,241 | $308,353,321 | 6.29% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
11,526,971 | $286,329,959 | 5.84% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
3,600,000 | $252,540,000 | 5.15% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
4,300,000 | $249,873,000 | 5.10% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
4,279,848 | $206,288,673 | 4.21% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
1,100,000 | $185,922,000 | 3.79% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
4,532,374 | $182,337,406 | 3.72% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
19,686,282 | $166,742,808 | 3.40% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
4,106,067 | $165,187,075 | 3.37% | |
| ALMS |
Alumis Inc.
Healthcare
|
6,772,595 | $149,200,267 | 3.04% |
Portfolio Trend
18 quarters · across all stocks
Holdings in BEAM
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,558,829 | 820,765 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $6,166,890 | 315,765 | Shares | Sole | 2025-05-15 | |
| 2023-09-30 | $24,426,166 | 1,015,641 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $42,061,899 | 1,317,316 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $38,275,000 | 1,250,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $45,620,759 | 1,166,473 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,640,000 | 1,000,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,387,500 | 1,250,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $43,762,875 | 763,750 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $55,783,000 | 700,000 | Shares | Sole | 2022-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||